Tandem Diabetes Care (TNDM) shares fell nearly 1% in recent Wednesday trading after Morgan Stanley downgraded the stock.
The firm lowered its rating to equalweight from overweight and adjusted its price target to $22 from $45.
Trading volume stood at over 1.1 million shares versus the daily average of about 1.4 million.
Price: 19.34, Change: -0.15, Percent Change: -0.77